Clinical Trials

NCT02696993 | ACTIVE_NOT_RECRUITING | PHASE1/PHASE2
80 Participants

Nivolumab and Radiation Therapy With or Without Ipilimumab in Treating Patients With Brain Metastases From Non-small Cell Lung Cancer

Study Type: INTERVENTIONAL
Last Updated: 2025-11-10
Start Date: 2016-12-16
Completion: 2027-12-31
Conditions
Metastatic Malignant Neoplasm in the Brain Stage IV Non-Small Cell Lung Cancer AJCC v7
Interventions
PROCEDURE BIOLOGICAL OTHER RADIATION
No Results Yet
NCT02684838 | COMPLETED
272 Participants

Vigilant ObservatIon of GlIadeL WAfer ImplaNT Registry

Study Type: OBSERVATIONAL
Last Updated: 2025-11-10
Start Date: 2016-04-26
Completion: 2025-06-23
Conditions
CNS Tumor
No Results Yet
NCT02683993 | COMPLETED | NA
20 Participants

Utilizing Holmium Laser for FURS Renal Stone Lithotripsy Comparing Stone Breaking vs. Stone Dusting Settings

Study Type: INTERVENTIONAL
Last Updated: 2025-11-10
Start Date: 2016-02-29
Completion: 2017-01-31
Conditions
Stone Clearance
Interventions
DEVICE
NCT02642042 | ACTIVE_NOT_RECRUITING | PHASE2
60 Participants

Trametinib and Docetaxel in Treating Patients With Recurrent or Stage IV KRAS Mutation Positive Non-small Cell Lung Cancer

Study Type: INTERVENTIONAL
Last Updated: 2025-11-10
Start Date: 2016-07-18
Completion: 2019-05-15
Conditions
KRAS Gene Mutation Recurrent Lung Non-Small Cell Carcinoma Stage IV Lung Non-Small Cell Cancer AJCC v7
Interventions
DRUG OTHER
NCT02623439 | TERMINATED | PHASE2
10 Participants

A Study of Haploidentical Bone Marrow Transplant for Patients With Hematologic Malignancies

Study Type: INTERVENTIONAL
Last Updated: 2025-11-10
Start Date: 2012-09-21
Completion: 2016-05-12
Conditions
Hematologic Malignancies
Interventions
DRUG
NCT02609776 | ACTIVE_NOT_RECRUITING | PHASE1
751 Participants

Study of Amivantamab, a Human Bispecific EGFR and cMet Antibody, in Participants With Advanced Non-Small Cell Lung Cancer

Study Type: INTERVENTIONAL
Last Updated: 2025-11-10
Start Date: 2016-05-24
Completion: 2026-12-31
Conditions
Non-Small-Cell Lung Cancer
Interventions
DRUG
No Results Yet
NCT02567435 | ACTIVE_NOT_RECRUITING | PHASE3
325 Participants

Combination Chemotherapy With or Without Temsirolimus in Treating Patients With Intermediate Risk Rhabdomyosarcoma

Study Type: INTERVENTIONAL
Last Updated: 2025-11-10
Start Date: 2016-06-01
Completion: 2023-06-30
Conditions
Alveolar Rhabdomyosarcoma Botryoid-Type Embryonal Rhabdomyosarcoma Embryonal Rhabdomyosarcoma Rhabdomyosarcoma Sclerosing Rhabdomyosarcoma Spindle Cell Rhabdomyosarcoma
Interventions
DRUG BIOLOGICAL OTHER RADIATION
NCT02546661 | ACTIVE_NOT_RECRUITING | PHASE1
117 Participants

Open-Label, Randomised, Multi-Drug, Biomarker-Directed, Phase 1b Study in Pts w/ Muscle Invasive Bladder Cancer

Study Type: INTERVENTIONAL
Last Updated: 2025-11-10
Start Date: 2016-12-28
Completion: 2020-03-18
Conditions
Muscle Invasive Bladder Cancer
Interventions
DRUG
No Results Yet
NCT02531516 | ACTIVE_NOT_RECRUITING | PHASE3
1503 Participants

An Efficacy and Safety Study of JNJ-56021927 (Apalutamide) in High-risk Prostate Cancer Subjects Receiving Primary Radiation Therapy: ATLAS

Study Type: INTERVENTIONAL
Last Updated: 2025-11-10
Start Date: 2015-11-19
Completion: 2026-06-30
Conditions
Prostatic Neoplasms
Interventions
DRUG RADIATION
No Results Yet
NCT02506153 | ACTIVE_NOT_RECRUITING | PHASE3
1301 Participants

Physician/Patient Choice of Either High-Dose Recombinant Interferon Alfa-2B or Ipilimumab, Versus Pembrolizumab in Treating Patients With Stage III-IV High Risk Melanoma That Has Been Removed by Surgery

Study Type: INTERVENTIONAL
Last Updated: 2025-11-10
Start Date: 2015-11-10
Completion: 2023-09-15
Conditions
Clinical Stage III Cutaneous Melanoma AJCC v8 Clinical Stage IV Cutaneous Melanoma AJCC v8 Metastatic Cutaneous Melanoma Metastatic Mucosal Melanoma Metastatic Non-Cutaneous Melanoma Non-Cutaneous Melanoma Recurrent Cutaneous Melanoma Recurrent Mucosal Melanoma Recurrent Non-Cutaneous Melanoma
Interventions
PROCEDURE BIOLOGICAL OTHER
NCT02495896 | ACTIVE_NOT_RECRUITING | PHASE1
61 Participants

Recombinant EphB4-HSA Fusion Protein With Standard Chemotherapy Regimens in Treating Patients With Advanced or Metastatic Solid Tumors

Study Type: INTERVENTIONAL
Last Updated: 2025-11-10
Start Date: 2015-09-03
Completion: 2021-04-01
Conditions
Head and Neck Squamous Cell Carcinoma Metastatic Pancreatic Adenocarcinoma Non-Resectable Cholangiocarcinoma Pancreatic Adenocarcinoma Recurrent Gallbladder Carcinoma Recurrent Non-Small Cell Lung Carcinoma Stage III Pancreatic Cancer Stage IIIA Gallbladder Cancer Stage IIIA Non-Small Cell Lung Cancer Stage IIIB Gallbladder Cancer Stage IIIB Non-Small Cell Lung Cancer Stage IV Gallbladder Cancer Stage IV Non-Small Cell Lung Cancer Stage IV Pancreatic Cancer Unresectable Gallbladder Carcinoma Unresectable Pancreatic Cancer
Interventions
DRUG OTHER BIOLOGICAL
No Results Yet
NCT02455531 | ACTIVE_NOT_RECRUITING
237 Participants

Long-term Outcomes of Children With Hypoplastic Left Heart Syndrome and the Impact of Norwood Shunt Type

Study Type: OBSERVATIONAL
Last Updated: 2025-11-10
Start Date: 2015-06-30
Completion: 2020-10-31
Conditions
Heart Defects
NCT02445781 | RECRUITING | EARLY_PHASE1
32 Participants

Differing Levels of Hypoglycemia

Study Type: INTERVENTIONAL
Last Updated: 2025-11-10
Start Date: 2015-07-31
Completion: 2026-09-30
Conditions
Hypoglycemia
Interventions
DEVICE
No Results Yet
NCT02420847 | ACTIVE_NOT_RECRUITING | PHASE1/PHASE2
57 Participants

Ixazomib Citrate With Gemcitabine Hydrochloride and Doxorubicin Hydrochloride in Treating Patients With Urothelial Cancer That is Metastatic or Cannot Be Removed by Surgery

Study Type: INTERVENTIONAL
Last Updated: 2025-11-10
Start Date: 2015-07-03
Completion: 2025-12-31
Conditions
Metastatic Urothelial Carcinoma Transitional Cell Carcinoma Unresectable Transitional Cell Carcinoma
Interventions
DRUG
No Results Yet
NCT02381886 | ACTIVE_NOT_RECRUITING | PHASE1
166 Participants

A Study of IDH305 in Patients With Advanced Malignancies That Harbor IDH1R132 Mutations

Study Type: INTERVENTIONAL
Last Updated: 2025-11-10
Start Date: 2015-03-06
Completion: 2016-12-07
Conditions
Advanced Malignancies That Harbor IDHR132 Mutations
Interventions
DRUG
No Results Yet
NCT02354014 | RECRUITING | PHASE2
60 Participants

Pharmacokinetic Study to Evaluate Anti-mycobacterial Activity of TMC207 in Combination With Background Regimen (BR) of Multidrug Resistant Tuberculosis (MDR-TB) Medications for Treatment of Children/Adolescents Pulmonary MDR-TB

Study Type: INTERVENTIONAL
Last Updated: 2025-11-10
Start Date: 2016-05-03
Completion: 2027-02-11
Conditions
Multidrug-Resistant Tuberculosis
Interventions
DRUG
No Results Yet
NCT02337985 | ACTIVE_NOT_RECRUITING | PHASE1
10 Participants

Gene Therapy and Combination Chemotherapy in Treating Patients With AIDS-Related Non-Hodgkin Lymphoma

Study Type: INTERVENTIONAL
Last Updated: 2025-11-10
Start Date: 2015-11-20
Completion: 2026-09-08
Conditions
AIDS-Related Burkitt Lymphoma AIDS-Related Diffuse Large B-cell Lymphoma AIDS-Related Plasmablastic Lymphoma AIDS-Related Primary Effusion Lymphoma HIV Infection AIDS Related Non-Hodgkin Lymphoma
Interventions
DRUG BIOLOGICAL
No Results Yet
NCT02321501 | ACTIVE_NOT_RECRUITING | PHASE1
37 Participants

Ceritinib and Everolimus in Treating Patients With Locally Advanced or Metastatic Solid Tumors or Stage IIIB-IV Non-small Cell Lung Cancer

Study Type: INTERVENTIONAL
Last Updated: 2025-11-10
Start Date: 2016-06-22
Completion: 2026-12-31
Conditions
ALK Positive Locally Advanced Malignant Solid Neoplasm Metastatic Malignant Solid Neoplasm ROS1 Gene Rearrangement Stage IIIB Lung Non-Small Cell Cancer AJCC v7 Stage IV Lung Non-Small Cell Cancer AJCC v7
Interventions
DRUG OTHER
No Results Yet
NCT02311933 | ACTIVE_NOT_RECRUITING | PHASE2
81 Participants

Tamoxifen Citrate or Z-Endoxifen Hydrochloride in Treating Patients With Locally Advanced or Metastatic, Estrogen Receptor-Positive, HER2-Negative Breast Cancer

Study Type: INTERVENTIONAL
Last Updated: 2025-11-10
Start Date: 2015-05-28
Completion: 2020-11-06
Conditions
Recurrent Breast Carcinoma Stage III Breast Cancer AJCC v7 Stage IIIA Breast Cancer AJCC v7 Stage IIIB Breast Cancer AJCC v7 Stage IIIC Breast Cancer AJCC v7 Stage IV Breast Cancer AJCC v6 and v7
Interventions
DRUG OTHER
NCT02280161 | RECRUITING
2000 Participants

Germ-Line Mutations in Blood and Saliva Samples From Patients With Cancer

Study Type: OBSERVATIONAL
Last Updated: 2025-11-10
Start Date: 2014-09-16
Completion: 2026-09-16
Conditions
Malignant Neoplasm
Interventions
OTHER
No Results Yet
NCT02253316 | ACTIVE_NOT_RECRUITING | PHASE2
236 Participants

Phase II Study of IRD (Ixazomib, Lenalidomide, Dexamethasone) Post Autologous Stem Cell Transplantation Followed by Maintenance Ixazomib or Lenalidomide for Multiple Myeloma

Study Type: INTERVENTIONAL
Last Updated: 2025-11-10
Start Date: 2015-01-20
Completion: 2020-02-05
Conditions
Multiple Myeloma
Interventions
BIOLOGICAL DRUG
NCT02210117 | ACTIVE_NOT_RECRUITING | EARLY_PHASE1
104 Participants

Nivolumab With or Without Bevacizumab or Ipilimumab Before Surgery in Treating Patients With Metastatic Kidney Cancer That Can Be Removed by Surgery

Study Type: INTERVENTIONAL
Last Updated: 2025-11-10
Start Date: 2014-11-25
Completion: 2025-12-31
Conditions
Clear Cell Renal Cell Carcinoma Metastatic Kidney Carcinoma Stage IV Renal Cell Cancer AJCC v7
Interventions
BIOLOGICAL PROCEDURE OTHER
No Results Yet
NCT02180867 | ACTIVE_NOT_RECRUITING | PHASE2/PHASE3
140 Participants

Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Before Surgery in Treating Patients With Newly Diagnosed Non-rhabdomyosarcoma Soft Tissue Sarcomas That Can Be Removed by Surgery

Study Type: INTERVENTIONAL
Last Updated: 2025-11-10
Start Date: 2014-07-11
Completion: 2019-06-30
Conditions
Alveolar Soft Part Sarcoma Angiomatoid Fibrous Histiocytoma Atypical Fibroxanthoma Clear Cell Sarcoma of Soft Tissue Epithelioid Malignant Peripheral Nerve Sheath Tumor Epithelioid Sarcoma Extraskeletal Myxoid Chondrosarcoma Extraskeletal Osteosarcoma Fibrohistiocytic Neoplasm Fibrosarcoma Inflammatory Myofibroblastic Tumor Intimal Sarcoma Leiomyosarcoma Liposarcoma Liver Embryonal Sarcoma Low Grade Fibromyxoid Sarcoma Low Grade Myofibroblastic Sarcoma Malignant Peripheral Nerve Sheath Tumor Malignant Skin Granular Cell Tumor Malignant Triton Tumor Mesenchymal Chondrosarcoma Myxofibrosarcoma Myxoid Chondrosarcoma Myxoinflammatory Fibroblastic Sarcoma Nerve Sheath Neoplasm PEComa Pericytic Neoplasm Plexiform Fibrohistiocytic Tumor Sclerosing Epithelioid Fibrosarcoma Skin Glomus Tumor Stage IB Soft Tissue Sarcoma AJCC v7 Stage IIB Soft Tissue Sarcoma AJCC v7 Stage III Soft Tissue Sarcoma AJCC v7 Stage IV Soft Tissue Sarcoma AJCC v7 Synovial Sarcoma Undifferentiated High Grade Pleomorphic Sarcoma of Bone
Interventions
DRUG RADIATION PROCEDURE
NCT02179086 | ACTIVE_NOT_RECRUITING | PHASE2
606 Participants

Dose-Escalated Photon IMRT or Proton Beam Radiation Therapy Versus Standard-Dose Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma

Study Type: INTERVENTIONAL
Last Updated: 2025-11-10
Start Date: 2014-12-04
Completion: 2025-12-31
Conditions
Glioblastoma
Interventions
RADIATION OTHER DRUG
No Results Yet
NCT02123758 | ACTIVE_NOT_RECRUITING | PHASE1
57 Participants

A Study of JNJ-56021927 (ARN-509) and Abiraterone Acetate in Participants With Metastatic Castration-Resistant Prostate Cancer

Study Type: INTERVENTIONAL
Last Updated: 2025-11-10
Start Date: 2014-07-09
Completion: 2016-06-27
Conditions
Prostatic Neoplasms Metastatic Castration-Resistant Prostate Cancer
Interventions
DRUG
No Results Yet
NCT02107989 | RECRUITING
700 Participants

Noninvasive Pre-surgical Evaluation of Patients With Focal Epilepsy and Establishment of a Normative Imaging Database

Study Type: OBSERVATIONAL
Last Updated: 2025-11-10
Start Date: 2014-03-11
Completion: 2028-03-30
Conditions
Epilepsy
Interventions
DEVICE
No Results Yet
NCT02003222 | ACTIVE_NOT_RECRUITING | PHASE3
488 Participants

Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia

Study Type: INTERVENTIONAL
Last Updated: 2025-11-10
Start Date: 2014-05-19
Completion: 2023-06-23
Conditions
Acute Lymphoblastic Leukemia B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative
Interventions
PROCEDURE BIOLOGICAL DRUG
NCT01964859 | RECRUITING | PHASE2
80 Participants

Feasibility Study for Fibroblast Autologous Skin Grafts

Study Type: INTERVENTIONAL
Last Updated: 2025-11-10
Start Date: 2015-01-07
Completion: 2027-12-02
Conditions
Wounds and Injuries
Interventions
BIOLOGICAL
No Results Yet
NCT01962636 | RECRUITING | NA
200 Participants

Umbilical Cord Blood Transplantation Using a Myeloablative Preparative Regimen for Hematological Diseases

Study Type: INTERVENTIONAL
Last Updated: 2025-11-10
Start Date: 2016-12-31
Completion: 2026-02-28
Conditions
Acute Myeloid Leukemia (AML) Acute Lymphocytic Leukemia (ALL) Chronic Myelogenous Leukemia Plasma Cell Leukemia Myelofibrosis Myelodysplasia Chronic Lymphocytic Leukemia Small Lymphocytic Lymphoma Marginal Zone B-Cell Lymphoma Follicular Lymphoma Lymphoplasmacytic Lymphoma Mantle-Cell Lymphoma Prolymphocytic Leukemia Diffuse Large B Cell Lymphoma Lymphoblastic Lymphoma Burkitt's Lymphoma Non-Hodgkin Lymphoma Multiple Myeloma
Interventions
DRUG RADIATION BIOLOGICAL
No Results Yet
NCT01955499 | ACTIVE_NOT_RECRUITING | PHASE1
39 Participants

Lenalidomide and Ibrutinib in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma

Study Type: INTERVENTIONAL
Last Updated: 2025-11-10
Start Date: 2013-09-24
Completion: 2024-11-06
Conditions
Recurrent Diffuse Large B-Cell Lymphoma Recurrent Follicular Lymphoma Recurrent Lymphoplasmacytic Lymphoma Recurrent Mantle Cell Lymphoma Recurrent Marginal Zone Lymphoma Refractory Diffuse Large B-Cell Lymphoma Refractory Follicular Lymphoma Refractory Lymphoplasmacytic Lymphoma Refractory Mantle Cell Lymphoma Refractory Marginal Zone Lymphoma
Interventions
PROCEDURE DRUG
No Results Yet
NCT01950390 | ACTIVE_NOT_RECRUITING | PHASE2
169 Participants

Ipilimumab With or Without Bevacizumab in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by Surgery

Study Type: INTERVENTIONAL
Last Updated: 2025-11-10
Start Date: 2014-01-24
Completion: 2021-10-06
Conditions
Stage IIIC Cutaneous Melanoma AJCC v7 Stage IV Cutaneous Melanoma AJCC v6 and v7 Unresectable Melanoma
Interventions
BIOLOGICAL
NCT01934660 | COMPLETED
150 Participants

Links Between Inflammation and Cardiometabolic Diseases

Study Type: OBSERVATIONAL
Last Updated: 2025-11-10
Start Date: 2013-12-02
Completion: 2022-08-03
Conditions
Diabetes Mellitus Cardiovascular Disease Healthy Volunteer Inflammation
Interventions
DRUG
No Results Yet
NCT01909245 | ACTIVE_NOT_RECRUITING | PHASE2
10 Participants

Islet Cell Transplant for Type 1 Diabetes

Study Type: INTERVENTIONAL
Last Updated: 2025-11-10
Start Date: 2013-10-16
Completion: 2026-09-22
Conditions
Type 1 Diabetes Mellitus
Interventions
BIOLOGICAL DRUG
No Results Yet
NCT01886872 | ACTIVE_NOT_RECRUITING | PHASE3
547 Participants

Rituximab and Bendamustine Hydrochloride, Rituximab and Ibrutinib, or Ibrutinib Alone in Treating Older Patients With Previously Untreated Chronic Lymphocytic Leukemia

Study Type: INTERVENTIONAL
Last Updated: 2025-11-10
Start Date: 2014-01-15
Completion: 2018-08-07
Conditions
Stage I Chronic Lymphocytic Leukemia Stage II Chronic Lymphocytic Leukemia Stage III Chronic Lymphocytic Leukemia Stage IV Chronic Lymphocytic Leukemia
Interventions
DRUG PROCEDURE OTHER BIOLOGICAL
NCT01867411 | COMPLETED
159 Participants

Multimodal Neuroimaging Genetic Biomarkers of Nicotine AddictionSeverity

Study Type: OBSERVATIONAL
Last Updated: 2025-11-10
Start Date: 2013-11-06
Completion: 2024-06-29
Conditions
Nicotine Dependence
No Results Yet
NCT01856192 | ACTIVE_NOT_RECRUITING | PHASE2
349 Participants

Rituximab and Combination Chemotherapy With or Without Lenalidomide in Treating Patients With Newly Diagnosed Stage II-IV Diffuse Large B Cell Lymphoma

Study Type: INTERVENTIONAL
Last Updated: 2025-11-10
Start Date: 2013-08-27
Completion: 2020-03-26
Conditions
Ann Arbor Stage II Diffuse Large B-Cell Lymphoma Ann Arbor Stage III Diffuse Large B-Cell Lymphoma Ann Arbor Stage IV Diffuse Large B-Cell Lymphoma
Interventions
DRUG OTHER BIOLOGICAL
NCT01850888 | COMPLETED | NA
15 Participants

MIBG for Refractory Neuroblastoma and Pheochromocytoma

Study Type: INTERVENTIONAL
Last Updated: 2025-11-10
Start Date: 2013-12-31
Completion: 2025-10-20
Conditions
Relapsed Neuroblastoma Metastatic Pheochromocytoma
Interventions
DRUG PROCEDURE
No Results Yet
NCT01841736 | ACTIVE_NOT_RECRUITING | PHASE2
171 Participants

Pazopanib Hydrochloride in Treating Patients With Progressive Carcinoid Tumors

Study Type: INTERVENTIONAL
Last Updated: 2025-11-10
Start Date: 2013-09-20
Completion: 2019-03-05
Conditions
Foregut Neuroendocrine Tumor Hindgut Neuroendocrine Tumor Metastatic Digestive System Neuroendocrine Tumor G1 Metastatic Neuroendocrine Tumor Midgut Neuroendocrine Tumor G1 Neuroendocrine Tumor G2 Recurrent Digestive System Neuroendocrine Tumor G1 Regional Digestive System Neuroendocrine Tumor G1
Interventions
PROCEDURE OTHER DRUG
NCT01804686 | RECRUITING | PHASE3
700 Participants

A Long-term Extension Study of PCI-32765 (Ibrutinib)

Study Type: INTERVENTIONAL
Last Updated: 2025-11-10
Start Date: 2013-09-09
Completion: 2026-12-31
Conditions
Chronic Lymphocytic Leukemia Small Lymphocytic Lymphoma Mantle Cell Lymphoma Follicular Lymphoma Diffuse Large B-cell Lymphoma Waldenstrom Macroglobulinemia Chronic Graft Versus Host Disease
Interventions
DRUG
No Results Yet
NCT01754363 | ACTIVE_NOT_RECRUITING | NA
1542 Participants

Survivorship of Attune Primary Total Knee Prosthesis

Study Type: INTERVENTIONAL
Last Updated: 2025-11-10
Start Date: 2013-02-01
Completion: 2030-02-01
Conditions
Noninflammatory Degenerative Joint Disease
Interventions
DEVICE
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page ยท Total 557382 trials